Cardiac sarcoidosis (CS) is a rare but potentially fatal condition that may present with a wide
range of clinical manifestations including congestive heart failure, conduction abnormalities …

Cardiac involvement in patients with sarcoidosis is being increasingly recognised and is
associated with poor prognosis. Although environmental and genetic factors have been …

Sarcoidosis is a systemic granulomatous disease of unknown cause. Sarcoidosis involving
the heart, ie, cardiac sarcoidosis, affects the prognosis of patients significantly as it may lead …

The Topol Solution gives you a complete print and multimedia package consisting of
Textbook of Cardiovascular Medicine, Third Edition, a DVD, and access to a wealth of online …

This retrospective study concerned 18 female and 23 male patients with cardiac sarcoidosis
(CS). The average age at CS diagnosis was 38 years. CS was observed in white (73% of …

Sarcoidosis is a multisystem disorder of unknown cause, and cardiac sarcoidosis affects at
least 25% of patients and accounts for substantial mortality and morbidity from this disease …

Clinically evident sarcoidosis involving the heart has been noted in at least 2 to 7% of
patients with sarcoidosis, but occult involvement is much higher (> 20%). Cardiac …

Objectives This study aimed to determine the prevalence on cardiac magnetic resonance
(CMR) of right ventricular (RV) systolic dysfunction and RV late gadolinium enhancement …

The records of 88 patients with systemic sarcoidosis who underwent 2-dimensional
echocardiography were reviewed to define the typical echocardiographic abnormalities in …

Cardiac involvement in patients with sarcoidosis includes a variety of clinical manifestations
such as advanced heart block, malignant ventricular arrhythmias, mitral regurgitation due to …